Thu, May 26, 2022 11:00 AM – 12:00 PM EDT


As the call for more diversity in clinical research grows, new approaches are needed to ensure patients of different genders, ethnicities, income brackets, and other under-represented populations are included in the evaluation of treatment access, effectiveness, and safety.

Real-world data (RWD) can help with eliminating bias, reaching different patient populations, and analyzing patient journeys based on varying factors. Join OM1 as we explore:

  • RWD methods for conducting more equitable research programs both pre and post approval, including post-marketing surveillance
  • Issues and Considerations when linking and leveraging social determinants of health (SDoH) data
  • Use cases in different specialty areas, including dermatology and mental health

**Please be advised this webinar is intended primarily for biopharmaceutical and medical device companies. Due to the proprietary nature of the content, vendors and consultants’ registration approval is at the discretion of OM1.